ENTRY       D00520                      Drug
NAME        Dimenhydrinate (JP18/USP/INN);
            Dramamine (TN)
PRODUCT
  GENERIC   DIMENHYDRINATE (Fresenius Kabi USA)
FORMULA     C17H21NO. C7H7ClN4O2
EXACT_MASS  469.1881
MOL_WEIGHT  469.9638
CLASS       Anti-allergic agent
             DG01557  Histamine receptor antagonist
              DG01482  Histamine receptor H1 antagonist
            Respiratory system agent
             DG01616  Xanthine derivative
REMARK      Therapeutic category: 1331
            ATC code: R06AA11
            Chemical structure group: DG00390
            Product (DG00390): D00300<JP> D00669<JP/US> D03360<JP> D00520<JP/US>
EFFICACY    Anti-emetic, Antivertigo, H1 receptor antagonist
COMMENT     Prevention and treatment of nausea, vomiting, or vertigo of motion sickness
TARGET      HRH1 [HSA:3269] [KO:K04149]
  PATHWAY   hsa04020(3269)  Calcium signaling pathway
            hsa04080(3269)  Neuroactive ligand-receptor interaction
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             R RESPIRATORY SYSTEM
              R06 ANTIHISTAMINES FOR SYSTEMIC USE
               R06A ANTIHISTAMINES FOR SYSTEMIC USE
                R06AA Aminoalkyl ethers
                 R06AA11 Dimenhydrinate
                  D00520  Dimenhydrinate (JP18/USP/INN) &lt;JP/US&gt;
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              13  Agents affecting sensory organs
               133  Vertigo agents
                1331  Dimenhydrinates
                 D00520  Dimenhydrinate (JP18/USP/INN)
            Classification of Japanese OTC drugs [BR:br08313]
             Agents for nervous and sensory systems
              06 Antivertigo drugs (incl. motion/morning sickness remedies)
               D00520  Dimenhydrinate (JP18/USP/INN)
            Risk category of Japanese OTC drugs [BR:br08312]
             Second-class OTC drugs
              Inorganic and organic chemicals
               Dimenhydrinate
                D00520  Dimenhydrinate (JP18/USP/INN)
            Drug groups [BR:br08330]
             Anti-allergic agent
              DG01557  Histamine receptor antagonist
               DG01482  Histamine receptor H1 antagonist
                DG00390  Diphenhydramine
                 D00520  Dimenhydrinate
             Respiratory system agent
              DG01616  Xanthine derivative
               D00520  Dimenhydrinate
            Drug classes [BR:br08332]
             Anti-allergic agent
              DG01482  Histamine receptor H1 antagonist
               D00520  Dimenhydrinate
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Histamine
                HRH1
                 D00520  Dimenhydrinate (JP18/USP/INN) &lt;JP/US&gt;
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00520  Dimenhydrinate
              D00520  Dimenhydrinate tablets
            Drug groups [BR:br08330]
             Anti-allergic agent
              DG01557  Histamine receptor antagonist
               DG01482  Histamine receptor H1 antagonist
                DG00390  Diphenhydramine
DBLINKS     CAS: 523-87-5
            PubChem: 7847586
            ChEBI: 4604
            LigandBox: D00520
            NIKKAJI: J252.867C
ATOM        33
            1   C8y C    24.0335  -15.5458
            2   C8y C    24.0335  -16.9748
            3   C8y C    25.2341  -14.8371
            4   N4x N    22.7217  -15.1124
            5   N4y N    25.2341  -17.6599
            6   N5x N    22.7217  -17.4080
            7   N4y N    26.4579  -15.5750
            8   O5x O    25.2341  -13.4551
            9   C8y C    21.9077  -16.2720
            10  C8y C    26.4579  -16.9220
            11  C1a C    25.2341  -19.0946
            12  C1a C    27.7111  -14.8957
            13  X   Cl   20.5022  -16.2778
            14  O5x O    27.7111  -17.6248
            15  C1c C    13.1842  -16.5304
            16  C8y C    11.9719  -17.2389
            17  C8y C    14.4022  -17.2389
            18  O2a O    13.1900  -15.1308
            19  C8x C    11.9719  -18.6326
            20  C8x C    10.7597  -16.5304
            21  C8x C    14.3965  -18.6326
            22  C8x C    15.6088  -16.5304
            23  C1b C    14.4022  -14.4280
            24  C8x C    10.7597  -19.3296
            25  C8x C     9.5475  -17.2389
            26  C8x C    15.6088  -19.3296
            27  C8x C    16.8209  -17.2389
            28  C8x C     9.5475  -18.6326
            29  C8x C    16.8150  -18.6326
            30  C1b C    15.6064  -15.1220
            31  N1c N    16.7880  -14.4384
            32  C1a C    17.9856  -15.1287
            33  C1a C    16.7870  -13.0368
BOND        35
            1     1   2 2
            2     1   3 1
            3     1   4 1
            4     2   5 1
            5     2   6 1
            6     3   7 1
            7     3   8 2
            8     4   9 1
            9     5  10 1
            10    5  11 1
            11    7  12 1
            12    9  13 1
            13   10  14 2
            14    6   9 2
            15    7  10 1
            16   15  16 1
            17   15  17 1
            18   15  18 1
            19   16  19 1
            20   16  20 2
            21   17  21 2
            22   17  22 1
            23   18  23 1
            24   19  24 2
            25   20  25 1
            26   21  26 1
            27   22  27 2
            28   24  28 1
            29   26  29 2
            30   25  28 2
            31   27  29 1
            32   23  30 1
            33   30  31 1
            34   31  32 1
            35   31  33 1
///
